195 related articles for article (PubMed ID: 16051392)
1. Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.
Salvatore MF; Fisher B; Surgener SP; Gerhardt GA; Rouault T
Brain Res Mol Brain Res; 2005 Oct; 139(2):341-7. PubMed ID: 16051392
[TBL] [Abstract][Full Text] [Related]
2. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
3. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
4. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
5. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
[TBL] [Abstract][Full Text] [Related]
6. Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
J Neurochem; 2006 Feb; 96(4):950-9. PubMed ID: 16412098
[TBL] [Abstract][Full Text] [Related]
7. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.
Salvatore MF; Calipari ES; Jones SR
ACS Chem Neurosci; 2016 Jul; 7(7):941-51. PubMed ID: 27124386
[TBL] [Abstract][Full Text] [Related]
9. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
[TBL] [Abstract][Full Text] [Related]
11. Polychlorinated biphenyl-induced neurotoxicity in organotypic cocultures of developing rat ventral mesencephalon and striatum.
Lyng GD; Snyder-Keller A; Seegal RF
Toxicol Sci; 2007 May; 97(1):128-39. PubMed ID: 17324953
[TBL] [Abstract][Full Text] [Related]
12. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
13. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.
Klejbor I; Myers JM; Hausknecht K; Corso TD; Gambino AS; Morys J; Maher PA; Hard R; Richards J; Stachowiak EK; Stachowiak MK
J Neurochem; 2006 Jun; 97(5):1243-58. PubMed ID: 16524369
[TBL] [Abstract][Full Text] [Related]
15. Non-serine-phosphorylated tyrosine hydroxylase expressing neurons are present in mouse striatum, accumbens and cortex that increase in number following dopaminergic denervation.
Depboylu C
J Chem Neuroanat; 2014 Mar; 56():35-44. PubMed ID: 24553202
[TBL] [Abstract][Full Text] [Related]
16. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of dopaminergic cell markers in the adult zebrafish forebrain.
Yamamoto K; Ruuskanen JO; Wullimann MF; Vernier P
J Comp Neurol; 2011 Feb; 519(3):576-98. PubMed ID: 21192085
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in dopamine- and vesicular monoamine-transporter functions.
Dluzen DE; McDermott JL
Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
[TBL] [Abstract][Full Text] [Related]
19. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals.
Salahpour A; Medvedev IO; Beaulieu JM; Gainetdinov RR; Caron MG
Biol Psychiatry; 2007 Jan; 61(1):65-9. PubMed ID: 16712807
[TBL] [Abstract][Full Text] [Related]
20. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
